In a clinical trial, the drug remdesivir shortened recovery time for patients with advanced cases of COVID-19, the disease caused by the coronavirus.
The coronavirus outbreak has put science on hold. Now there are discoveries that may never be made and patients who will miss the chance at a breakthrough cure.Fauci, who took the helm of the infectious-disease agency in 1984, likened the new findings to the 1986 discovery that the anti-retroviral drug azidothymidine, or AZT, could suppress the HIV virus in patients with AIDS.
On Wednesday, Fauci suggested the remdesivir results could upend a welter of other clinical trials now underway to explore potential treatments for COVID-19.The NIAID trial began on Feb. 21 and enrolled 1,063 patients across the country. The first participant was an American who became ill after traveling on the Diamond Princess cruise ship and was treated at the University of Nebraska. A total of 68 sites ultimately joined the study, including 47 in the United States and 21 in Europe and Asia.
That’s welcome news considering that the drug is not yet rolling off of production lines in large quantities. With limited stocks now in hand, and coronavirus cases continuing to pile up, the new findings suggest the medication could go twice as far as previously thought possible.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gilead reports 'positive data' on remdesivir coronavirus drug trial
Read more »
Dr. Anthony Fauci says data from remdesivir coronavirus drug trial shows 'quite good news'CNBC's Meg Tirrell breaks down White House health advisor Dr. Anthony Fauci's comments on Gilead's possible coronavirus treatment.
Read more »
Fauci: Remdesivir trial is 'opening the door' to possible coronavirus treatmentsDr. Fauci speaks on the clinical trial for potential coronavirus treatment drug remdesivir: “What it has proven is that a drug can block this virus ... This drug happens to be blocking an enzyme that the virus uses.'
Read more »
Gilead says early results of coronavirus drug trial show improvement with shorter remdesivir treatmentGilead says preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a 5-day dosage of remdesivir improved, and more than half were discharged from the hospital within 2 weeks.
Read more »
Cramer: Promising data from coronavirus drug trial 'beginning of the end of the true nightmare'CNBC's Jim Cramer said Wednesday that positive news from Gilead Sciences about a potential treatment for the coronavirus marked a turning point in the fight against Covid-19.
Read more »
Coronavirus Drug Shows Promising Results, According to Drug MakerRemdesivir Shows Promising Results as a Coronavirus Treatment, According to Drug Manufacturer Gilead
Read more »